6505--Perphenazine Tablets (VA-25-00037353)
ID: 36E79725R0030Type: Solicitation
AwardedJun 17, 2025
$1.3M$1,260,191
AwardeeGOLDEN STATE MEDICAL SUPPLY, INC. CAMARILLO 93012-8601
Award #:36E79725D0040
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/d48003a983da4f7e94b4df0401d7e284/view
Timeline
    Description

    The Department of Veterans Affairs is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to ensure a reliable supply of this pharmaceutical product for both the Department of Veterans Affairs and the Department of Defense, with a focus on service-disabled veteran-owned, women-owned, and HUBZone small businesses. The procurement process will adhere to the Drug Supply Chain Security Act and require compliance with FDA regulations, including Good Manufacturing Practices. Interested offerors must submit their proposals by May 1, 2025, at 2:30 PM CDT, and can direct inquiries to Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov.

    Point(s) of Contact
    Anthony DiCrescenzoContract Specialist
    Anthony.DiCrescenzo@va.gov
    Files
    Title
    Posted
    36E79725R0030_1.docx
    The Department of Veterans Affairs (VA) is preparing to issue Request for Proposal (RFP) 36E79725R0030 for the procurement of Perphenazine Tablets. This is an unrestricted solicitation that will supply not only the VA but also the Department of Defense, the Bureau of Prisons, the Indian Health Service, and Federal Health Care Centers. The successful contractor will ensure a continuous supply for one year, with optional extensions for up to four additional years. The proposal is expected to be released electronically around April 10, 2025, with submissions due by April 24, 2025. Offerors must provide unique NDC numbers and specify the drug name as it appears on the label. The total estimated annual requirements consist of four variations of Perphenazine Tablets, with yearly needs quantified for each dosage. No paper copies of the solicitation will be distributed, and interested parties must keep informed of any updates on SAM.gov. All responsible sources are encouraged to submit a proposal, with primary inquiries directed to the point of contact, Anthony Di Crescenzo, via email.
    36E79725R0030 - Final.docx
    The document details a government Request for Proposal (RFP) concerning the procurement of Perphenazine tablets for the Department of Veterans Affairs (VA) and Department of Defense (DoD) through their Pharmaceutical Prime Vendor (PPV) Programs. The solicitation outlines the requirements for service-disabled veteran-owned small businesses, women-owned small businesses, and HUBZone small businesses to compete for a contract to supply specified quantities of the drug across multiple years, including a base year and four option years. Offerors must provide pricing that includes a 0.5% Cost Recovery Fee and a unique National Drug Code (NDC) for each product. The contract is aimed at ensuring a consistent supply of pharmaceutical products, adhering to the Drug Supply Chain Security Act (DSCSA), and establishing a structured evaluation process based on Fair Acquisition Regulations (FAR). Moreover, the contractor must maintain compliance with FDA regulations, including Good Manufacturing Practices (cGMP). The contract's overall objective is to streamline the procurement and distribution process, allowing the VA and DoD to efficiently fulfill their pharmaceutical needs while maintaining regulatory compliance and cost-effectiveness.
    36E79725R0030 0001.docx
    This government document is an amendment to solicitation 36E79725R0030 from the Department of Veterans Affairs, specifically issued by the OPAL/National Acquisition Center. The primary purpose of the amendment is to extend the due date for submission of offers from April 24, 2025, to May 1, 2025, at 2:30 PM CDT. All other terms and conditions of the solicitation remain unchanged. Offerors are reminded to acknowledge receipt of this amendment, which can be done through various methods including returning copies of the amendment, acknowledgment in submitted offers, or via a separate communication. The amendment underscores the importance of timely submission and adherence to solicitation requirements. The contracting officer responsible for this amendment is Nicholas McGregor, ensuring that all procedural steps are performed in accordance with federal guidelines.
    Similar Opportunities
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    VA Direct to Patient supply services
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to provide direct delivery supply services for medical and surgical items to Veteran patients through its Consolidated Mail Outpatient Pharmacy (CMOP) program. The contractor must demonstrate at least two years of experience, the capacity to process approximately 14 million prescriptions annually, and the ability to maintain compliance with federal and state regulations while ensuring a 48-hour average turnaround time for prescription fulfillment. This opportunity is critical for ensuring timely access to essential medical supplies for Veterans, with the contract structured to reimburse vendors per filled prescription at government contract prices, plus handling fees. Interested vendors must submit a capabilities statement to the primary contact, Phillip Reuwer, at Phillip.Reuwer@va.gov by January 11, 2026, with any questions directed to the same contact before January 8, 2026.
    COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM - 762 TUCSON
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is conducting a Sources Sought Notice to identify potential qualified domestic sources for the procurement of COLESTIPOL HCL 1GM TAB and DESONIDE 0.05% CREAM through its National CMOP Office. This announcement serves as a market research tool rather than a solicitation, aiming to gather information on vendors' capabilities to meet the requirements outlined in the Statement of Requirements. The products sought are critical for pharmaceutical preparation and will support the healthcare needs of veterans. Interested vendors must submit their responses, including company details and capability statements, via email to Jennifer Coleman at Jennifer.Coleman4@va.gov by December 19, 2025, at 3:00 PM CDT. This notice does not obligate the VA to issue a solicitation.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    Trazodone - Solicitation
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting offers for Trazodone HCL tablets in various dosages and bottle counts. This procurement aims to fulfill substantial pharmaceutical supply needs, emphasizing compliance with technical and quality requirements as outlined in the solicitation documents. The solicitation, identified as SPE2D2-26-R-0003, mandates electronic submissions via the Defense Logistics Agency Internet Bid Board System (DIBBS) by December 12, 2025, at 3:00 PM EST, with no alternative submission methods accepted. Interested parties can reach out to Nancy Fernandez at nancy.fernandez@dla.mil or Jason Wray at jason.wray@dla.mil for further inquiries.
    R499--Sterile Compounding Compliance QA Program
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 17, is seeking proposals for a Sterile Compounding Compliance Quality Assurance Program, specifically set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB). This program encompasses a range of services, including monthly garbing competency assessments, media fill tests, hazardous drug manipulation competency evaluations, and cleaning and disinfection competency checks, with a contract period extending from January 1, 2026, to December 31, 2030. The importance of this procurement lies in ensuring compliance and safety in sterile compounding practices, which are critical for patient care in healthcare settings. Interested parties must submit their proposals by December 5, 2025, at 12 PM CST, and can direct inquiries to Contracting Specialist Matt Lee at matthew.lee5@va.gov or by phone at 210-393-9281.